Company research / AMRX
Amneal Pharmaceuticals, Inc. (AMRX)
- Sector Manufacturing
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Amneal Pharmaceuticals, Inc. reported revenue of $3.02B. Revenue grew 8.0% from the prior annual period.
Key ratios (year ended 2025-12-31)
36.9%
Gross margin
13.1%
Operating margin
2.4%
Net margin
8.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.